Cite
HARVARD Citation
Lee, J. et al. (2023). Formation of CYP3A‐specific metabolites of ibrutinib in vitro is correlated with hepatic CYP3A activity and 4β‐hydroxycholesterol/cholesterol ratio. Clinical and translational science. 16 (2), pp. 279-291. [Online].